WS #16248
Abbott Laboratories has cut its 2026 sales growth view and announced a spin-off of its nutrition business, signaling mixed corporate health in the healthcare sector. Meanwhile, major names including Alphabet, Microsoft, Ford, and Phillips 66 are preparing for earnings reports that could move stocks by 3-5%, adding to near-term volatility. The market is closely watching these results for clues on consumer demand and industrial resilience amidst the energy shock.
Corporate Earnings and Guidance
Abbott Laboratories has cut its 2026 sales growth view and announced a spin-off of its nutrition business, signaling mixed corporate health in the healthcare sector. Meanwhile, major names including Alphabet, Microsoft, Ford, and Phillips 66 are preparing for earnings reports that could move stocks by 3-5%, adding to near-term volatility. The market is closely watching these results for clues on consumer demand and industrial resilience amidst the energy shock.